Rocket Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$1,148,117
32 notices · 336,069 sh
Oct 2025 to Oct 2026
Reported ·
$546,347
22 sales · 1 buy · $34,400 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 22 reported sales carry the 10b5-1 box. Together they are 0.15% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-15Militello John, See Remarks$22,730
2026-09-14Militello John, See Remarks$22,731
2026-09-11Wilson Martin, General Counsel$256,486
2026-09-11Militello John, See Remarks$30,368
2026-08-18Shah Gaurav, CEO$7,754
2026-08-18Wilson Martin, General Counsel$2,134
2026-08-18Militello John, See Remarks$4,234
2026-08-13Wilson Martin, General Counsel$11,810
2026-08-13Shah Gaurav, CEO$9,592
2026-08-11Stevens Christopher James, Chief Operating Officer$128,281
2026-08-11Chaudhuri Sarbani, See Remarks$16,451
2026-07-07Malik Fady Ibraham, Director$41,393
2026-05-21Shah Gaurav, CEO$171,821
Form 4, 2026-05-26: sold 55,684 at $3.09 Form 4 ↗
2026-05-19Shah Gaurav, CEO$7,262
Form 4, 2026-05-21: sold 2,409 at $3.01 Form 4 ↗
2026-05-19Militello John, See Remarks$1,158
Form 4, 2026-05-21: sold 384 at $3.01 Form 4 ↗
2026-05-19Wilson Martin, General Counsel$1,996
Form 4, 2026-05-21: sold 662 at $3.01 Form 4 ↗
2026-05-13Wilson Martin, General Counsel$12,118
Form 4, 2026-05-14: sold 3,361 at $3.61 Form 4 ↗
2026-05-13Shah Gaurav, CEO$9,836
Form 4, 2026-05-14: sold 2,728 at $3.61 Form 4 ↗
2026-05-13Militello John, See Remarks$3,083
Form 4, 2026-05-14: sold 855 at $3.61 Form 4 ↗
2026-05-07Chaudhuri Sarbani, See Remarks$67,741
Form 4, 2026-05-11: sold 17,650 at $3.84 Form 4 ↗
2026-02-18Militello John, See Remarks$3,863
Form 4, 2026-02-20: sold 1,157 at $3.34 Form 4 ↗
2026-02-18Wilson Martin, General Counsel$4,594
Form 4, 2026-02-20: sold 1,376 at $3.34 Form 4 ↗
2026-02-18Shah Gaurav, CEO$19,998
Form 4, 2026-02-20: sold 5,990 at $3.34 Form 4 ↗
2026-02-13Wilson Martin, General Counsel$40,583
Form 4, 2026-02-18: sold 12,253 at $3.31 Form 4 ↗
2026-02-13Shah Gaurav, CEO$40,669
Form 4, 2026-02-18: sold 12,279 at $3.31 Form 4 ↗
2026-02-13Schwartz Jonathan David, See Remarks$48,052
2026-02-13Militello John, See Remarks$12,341
Form 4, 2026-02-18: sold 3,726 at $3.31 Form 4 ↗
2025-11-18Schwartz Jonathan David, See Remarks$7,591
Form 4, 2025-11-20: sold 2,545 at $2.98 Form 4 ↗
2025-11-18Shah Gaurav, CEO$18,720
Form 4, 2025-11-20: sold 6,276 at $2.98 Form 4 ↗
2025-11-18Militello John, See Remarks$3,239
Form 4, 2025-11-20: sold 1,086 at $2.98 Form 4 ↗
2025-11-18Wilson Martin, General Counsel$4,910
Form 4, 2025-11-20: sold 1,646 at $2.98 Form 4 ↗